PET developer Positron of Houston posted higher revenues for 1994 (end-December) dueto increased service revenues and the sale of two PET cameraslast year. Positron's revenues for the year were $6.1 million,up 157% from $2.4 million in 1993. The
PET developer Positron of Houston posted higher revenues for 1994 (end-December) dueto increased service revenues and the sale of two PET cameraslast year. Positron's revenues for the year were $6.1 million,up 157% from $2.4 million in 1993. The company's net loss was$3.8 million, compared to a $3.3 million net loss in 1993. Positronshipped a scanner to Hadassah Medical School and Hospital in Jerusalemin December (SCAN 2/2/94).
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.